Navigation Links
Sale of Enzymatic Therapy, Inc. to Nature's Way Holding Company Finalized
Date:11/10/2008

Nature's Way Holding Company names Randy J. Rose President/CEO and Rory

Mahony Chief Operating Officer of new natural medicine powerhouse

GREEN BAY, Wis., Nov. 10 /PRNewswire/ -- Representatives of the Dr. Willmar Schwabe Group, of Karlsruhe, Germany, have confirmed that corporate ownership for Enzymatic Therapy, Inc., of Green Bay, Wisconsin, was transferred on Friday, October 31, 2008.

A shareholder group comprised of North Castle Partners, LLC, and members of Enzymatic Therapy Management previously owned Enzymatic Therapy, Inc.

Details of the sale price are unavailable, as is information regarding the combined revenue of the entities.

The North American operating platform for the Schwabe group will be named Nature's Way Holding Company, and will include the entire operations of Enzymatic Therapy, Inc. and Nature's Way Products Inc.

The combined group will create an organization with great depth of technical and scientific expertise that will market a very broad line of wellness products and natural medicines.

Nature's Way Holding Company will continue to bring trusted consumer solutions forward under highly popular brand names that include Nature's Way(tm), Alive(tm), Zucol(tm), Umcka(tm), Pearls(tm) Whole Body Cleanse(tm), Remifemin(R), and Enzymatic Therapy(R).

Additionally, the company will continue to market professional products sold only through medical professionals under labels that include Integrative Therapeutics(R).

Nature's Way Holding Company has confirmed to its customers that all merchandising and marketing programs previously announced for both product lines will continue. The Company also will continue to distribute products to over 40 countries outside the United States.

Randy J. Rose, formerly the President and CEO of Enzymatic Therapy, has been named the President and CEO of the combined business, and Rory Mahony, who previously served as COO & General Manager of Nature's Way, will be the Chief Operating Officer. Both Mr. Rose and Mr. Mahony will join the Board of Directors for the new corporate entity.

Nature's Way Holding Company operates manufacturing and distribution facilities in Utah and Wisconsin, and has offices across the United States, including those in New York City, St Louis, Missouri, Green Bay, Wisconsin, and in Springville, Utah. It also has a marketing and distribution company in Canada.

Consumer enthusiasm for the Enzymatic and Nature's Way products has resulted in strong and steady growth of the brands. Going forward, the company will focus on further acceleration of these very positive growth rates by continuing to deliver quality products that meet customer needs.


'/>"/>
SOURCE Nature's Way Holding Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. What Boomers Need to Know About Digestion; Enzymatic Therapy's CompleteGest1 Renew targets special digestive issues
2. Schwabe, World Leader in Herbal Manufacturing Will Acquire Enzymatic Therapy Through Natures Way Holding, Inc.
3. Dr. Ajrawats Air-Pulse Autonomic Meditation Therapy, a Revolutionary, Scientific, Meditation Therapy, Receives Patent Trademark
4. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
5. Skin flaps deliver cancer-fighting therapy, ASPS study reveals
6. American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Womens Shelters
7. Smoking Cessation Rates Double With Intensive Counseling and Free Nicotine Replacement Therapy, Studies of 20,000 Smokers Show
8. To evade chemotherapy, some cancer cells mimic stem cells
9. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
10. Statement Regarding the Filing of Signatures to Put the Human Embryo Stem Cell Issue on the November Statewide Ballot
11. As I-1000 Signatures are Counted, Washington State Medical Association Opposition to Physician-Assisted Suicide Reiterated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... (PRWEB) , ... September 20, ... ... a software company specializing in medical device compliance and commercialization, has just ... risk management activities. , FDA is more adamant than ever about medical ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... innovation, the company recently unveiled a redesigned website. The new site – still ... of building owners, architects, contractors and other industry users that Garland serves. , ...
(Date:9/20/2017)... ... September 20, 2017 , ... The ... “Humans With Vaginas.” The goal is to ignite conversation via social media and ... products. The brand has declared September “Humans with Vaginas” month, releasing a video ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... Health & ... and 30-Hour and HAZWOPER 8-, 24- and 40-Hour courses from now until November 30, ... In addition to offering these discounted prices to all businesses and government agencies – ...
(Date:9/20/2017)... ... 20, 2017 , ... “Finn Mouseson”: follows the exciting story of a mouse ... mouse sets out on a journey that will show that friends are to be ... newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s degree in ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... , Sept. 5, 2017  Xyntek Inc. has announced another milestone in their ... Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 West Adams ... ... engagements regionally. ...
(Date:9/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... its meeting with the U.S. Food and Drug Administration ... At the meeting, ... for submission of ORMD-0801, would be a Biologics License ...
(Date:9/1/2017)... will present the latest research from across its growing oncology ... Congress, September 8-12 in Madrid, Spain . ... on Bayer,s marketed portfolio and late-stage compounds as well as ... "We value the opportunity to meet with ... said Carsten Brunn , Head of Pharmaceuticals, Americas Region ...
Breaking Medicine Technology: